Clinical application of clustered-AChR for the detection of SNMG

Myasthenia gravis (MG) is an autoantibody-mediated disease of the neuromuscular junction (NMJ). However, accumulating evidence has indicated that MG patients whose serum anti-acetylcholine receptor (AChR) antibodies are not detectable (serumnegative MG; SNMG) in routine assays share similar clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Guang, Wang, Xiaoqing, Yu, Xiaowen, Zhang, Xiutian, Guan, Yangtai, Jiang, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464178/
https://www.ncbi.nlm.nih.gov/pubmed/26068604
http://dx.doi.org/10.1038/srep10193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464178/
https://www.ncbi.nlm.nih.gov/pubmed/26068604
http://dx.doi.org/10.1038/srep10193

Ejemplares similares